Detection of Circulant Tumor Necrosis Factor-α, Soluble Tumor Necrosis Factor p75 and Interferon-γ in Brazilian Patients with Dengue Fever and Dengue Hemorrhagic Fever

Memorias do Instituto Oswaldo Cruz

Volumn 96, Issue 2, 2001, Pages 229-232

  Braga, Elzinandes L A ^a   Moura, Patrícia ^b   Pinto, Luzia M O ^a   Ignácio, Sonia R N ^a   Oliveira, Maria José C ^c   Cordeiro, Marly T ^c   Kubelka, Claire F ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^c Dr Milton Bezerra Laboratory   (Brazil)

Author keywords

Cytokines; Dengue; Dengue hemorrhagic fever

Indexed keywords

ALPHA INTERFERON; CYTOKINE; LEUKOCYTE ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 2;

ADULT; ARTICLE; BLOOD; BRAZIL; CHILD; DENGUE; HOSPITALIZATION; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION;

ADULT; ANTIGENS, CD; BRAZIL; CHILD; CYTOKINES; DENGUE; DENGUE HEMORRHAGIC FEVER; HUMANS; INTERFERON-ALPHA; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; SEVERITY OF ILLNESS INDEX; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035257445     PISSN: 00740276     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0074-02762001000200015     Document Type: Article

References (22)

1. Anderson R, Wang S, Osiowy C, Issekutz AC 1997. Activation of endothelial cells via antibody-enhanced dengue virus infection of peripheral blood monocytes. J Virol 71: 4226-4232.
2. Bethell DB, Flobbe K, Cao XT, Day NP, Pham TP, Buurman WA, Cardosa MJ, White NJ, Kwiatkowski D 1998. Pathophysiologic and prognostic role of cytokines in dengue hemorrhagic fever. J Infect Dis 177: 778-782.
3. Dinarello CA 1996. Cytokines as mediators in the pathogenesis of septic shock. In ET Rietschel, H Wagner (eds), Pathology of the Septic Shock, Springer-Verlag, Heidelberg, Germany, p. 134-165.
4. Eigle A, Sinha B, Hartmann G, Endres S 1997. Taming TNF: strategies to restrain this proinflammatory cytokine. Immunol Today 18: 487.
5. Halstead SB 1980. Immunological parameters of togaviruses disease syndromes. In RW Schlesinger, The Togaviruses. Biology, Structure, Replication, Academic Press, New York, p. 107-174.
6. Halstead SB 1990. Dengue and dengue hemorrhagic fever. Curr Scie 3: 434-438.
7. Hober D, Delannoy AS, Benyoucef S, De Groote D, Wattre P 1996. High levels of sTNFR p75 and TNF alpha in dengue infected patients. Microbiol Immunol 40: 569-573.
8. Hober D, Nguong VT, Shen L, Ha DQ, Benyoucef S, Nguong TH, Bui TM, Loan HK, Le BL, Bouzidi A, De Groote D, Drout MT, Deubel V, Wattre P 1998. Tumor necrosis factor alpha levels in plasma and whole-blood culture in dengue-infected patients: relationship between virus detection and pre-existing specific antibodies. J Med Virol 54: 210-218.
9. Hober D, Poli L, Roblin B, Gestas P, Chungue E, Granic G, Imbert P, Pecarere JL, Vergez-Pascal R, Wattre P, Maniez-Montreuil M 1993. Serum levels of tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6) and interleukin-1b (IL-1β) in Dengue-infected patients. Amer J Med Hyg 48: 324-331.
10. Iyngkaran N, Yadav M, Sinniah M 1995. Augmented inflammatory cytokines in primary dengue infection progressing to shock. Singapore Med J 36: 218-221.
11. Kliks SC, Nisalak A, Brant WE, Wahl L, Burke DS 1989. Antibody-dependent enhancement of Dengue virus growth in human monocytes as a risk factor for Dengue hemorrhagic fever. Amer J Trop Med Hyg 40: 444-451.
12. Kubelka CF, Borges PA, vonSydow FOF, Lampe E 1995. Analysis of tumor necrosis factor-α serum level in Brazilian patients with Dengue-2. Mem Inst Oswaldo Cruz 90: 741-742.
13. Kuno G, Bailey RE 1994. Cytokine responses to Dengue infection among Puerto Rican patients. Mem Inst Oswaldo Cruz 89: 179-182.
14. Leuwenberg JFM, Dentener MA, Buurman WA 1994. Lipopolysaccharide-mediated soluble TNF receptor release and TNF receptor expression by monocytes. J Immunol 152: 5070-5076.
15. Mantovani A, Bussolino F, Introna M 1997. Cytokine regulation of endotelial cell function: from molecular level to the bedside. Immunol Today 18: 231-240.
16. Nogueira RMR, Miagostovich MP, Cavalcanti SMB, Marzochi KBF, Schatzmayr H 1992. Levels of IgM antibodies against Dengue virus in Rio de Janeiro. Brasil. Res Virol 143: 423-427.
17. PAHO-Pan American Health Organization 1994. Dengue and dengue hemorrhagic fever in Americas: guidelines for prevention and control. PAHO/WHO Scientific Publication no. 548.
18. Pang T 1987. Dengue haemorrhagic fever: virus or response? Bio Essays 6: 141-143.
19. Pinto LMO, Oliveira SA, Braga ELA, Nogueira RMR, Kubelka CF 1999. Increased pro-inflammatory cytokines (TNF-α And IL-6) and anti-inflammatory compounds (sTNFRp75 and sTNFRp55) in Brazilian patients during exanthematic dengue fever. Mem Inst Oswaldo Cruz 94: 1-8.
20. Van Zee KJ, Kohno T, Fischer E, Rock CS, Moldawer LL, Lowry SF 1992. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor-α in vitro and in vivo. Proc Natl Acad Scie 89: 4845-4849.
21. Vassali P, 1992. The pathophysiology of tumor necrosis factors. Annu Rev Immunol 10: 411-452.
22. Yang KD, Lee CS, Hwang KP, Chu ML, Shaio MF 1995. A model to study cytokine profiles in primary and heterologously secondary Dengue-2 virus infections. Acta Virol 39: 19-21.